Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia

[1]  B. Bogerts,et al.  Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy , 2015, Schizophrenia Research.

[2]  Yu-Chih Shen,et al.  Resequencing and association study of the NFKB activating protein-like gene (NKAPL) in schizophrenia , 2014, Schizophrenia Research.

[3]  Terrence J. Sejnowski,et al.  Astrocytes contribute to gamma oscillations and recognition memory , 2014, Proceedings of the National Academy of Sciences.

[4]  P. Sullivan,et al.  Specific glial functions contribute to schizophrenia susceptibility. , 2014, Schizophrenia bulletin.

[5]  Jin U. Kang,et al.  Norepinephrine Controls Astroglial Responsiveness to Local Circuit Activity , 2014, Neuron.

[6]  M. Maier,et al.  Fibrillary astrocytes are decreased in the subgenual cingulate in schizophrenia , 2014, European Archives of Psychiatry and Clinical Neuroscience.

[7]  K. Petry,et al.  Aquaporin and brain diseases. , 2014, Biochimica et biophysica acta.

[8]  C. Shannon Weickert,et al.  Increased expression of astrocyte markers in schizophrenia: Association with neuroinflammation , 2014, The Australian and New Zealand journal of psychiatry.

[9]  G. Knott,et al.  Connexin 30 sets synaptic strength by controlling astroglial synapse invasion , 2014, Nature Neuroscience.

[10]  P. Holmans,et al.  Pathway Analyses Implicate Glial Cells in Schizophrenia , 2014, PloS one.

[11]  S. Oliet,et al.  Gliotransmitters Travel in Time and Space , 2014, Neuron.

[12]  Zhuojing Luo,et al.  The Proform of Glia Cell Line-Derived Neurotrophic Factor: a Potentially Biologically Active Protein , 2014, Molecular Neurobiology.

[13]  R. Schwarcz,et al.  Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: Implications for schizophrenia , 2014, Schizophrenia Research.

[14]  M. Sofroniew,et al.  Reactive Gliosis and the Multicellular Response to CNS Damage and Disease , 2014, Neuron.

[15]  A. James,et al.  The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review , 2013, Psychiatry Research: Neuroimaging.

[16]  J. van os,et al.  Replicated Evidence of Absence of Association between Serum S100B and (Risk of) Psychotic Disorder , 2013, PloS one.

[17]  H. Scharfman,et al.  Aquaporin-4 water channels and synaptic plasticity in the hippocampus , 2013, Neurochemistry International.

[18]  Haoyue Sun,et al.  Δ9-THC-Caused Synaptic and Memory Impairments Are Mediated through COX-2 Signaling , 2013, Cell.

[19]  A. Sawa,et al.  Cuprizone short-term exposure: Astrocytic IL-6 activation and behavioral changes relevant to psychosis , 2013, Neurobiology of Disease.

[20]  D. Bucci,et al.  The effect of transient increases in kynurenic acid and quinolinic acid levels early in life on behavior in adulthood: Implications for schizophrenia , 2013, Schizophrenia Research.

[21]  P. E. Gold,et al.  Modulation of multiple memory systems: From neurotransmitters to metabolic substrates , 2013, Hippocampus.

[22]  S. Hyman,et al.  Progress in the Genetics of Polygenic Brain Disorders: Significant New Challenges for Neurobiology , 2013, Neuron.

[23]  D. Rowitch,et al.  Evolving Concepts of Gliogenesis: A Look Way Back and Ahead to the Next 25 Years , 2013, Neuron.

[24]  J. Burns.  Pathways from Cannabis to Psychosis: A Review of the Evidence , 2013, Front. Psychiatry.

[25]  C. Beasley,et al.  Increased expression of glial fibrillary acidic protein in prefrontal cortex in psychotic illness , 2013, Schizophrenia Research.

[26]  E. Nagelhus,et al.  Physiological roles of aquaporin-4 in brain. , 2013, Physiological reviews.

[27]  Stephan Heckers,et al.  Definition and description of schizophrenia in the DSM-5 , 2013, Schizophrenia Research.

[28]  G. Church,et al.  Cas9 as a versatile tool for engineering biology , 2013, Nature Methods.

[29]  T. Hirota,et al.  Adenosine hypothesis in schizophrenia and bipolar disorder: A systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators , 2013, Schizophrenia Research.

[30]  A. Sawa,et al.  Mouse models of gene–environment interactions in schizophrenia , 2013, Neurobiology of Disease.

[31]  A. Sarandol,et al.  Increased plasma agmatine levels in patients with schizophrenia. , 2013, Journal of psychiatric research.

[32]  O. Bosler,et al.  Brain‐derived neurotrophic factor/TrkB signaling regulates daily astroglial plasticity in the suprachiasmatic nucleus: Electron‐microscopic evidence in mouse , 2013, Glia.

[33]  J. Alferink,et al.  Effects of Chronic D-Serine Elevation on Animal Models of Depression and Anxiety-Related Behavior , 2013, PloS one.

[34]  D. Bonifati,et al.  Innate Immunity and Neuroinflammation , 2013, Mediators of inflammation.

[35]  J. Coyle,et al.  Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction , 2013, Proceedings of the National Academy of Sciences.

[36]  K. Dev,et al.  Levels of S100B are raised in female patients with schizophrenia , 2013, BMC Psychiatry.

[37]  T. Sakurai,et al.  Roles of glial cells in schizophrenia: Possible targets for therapeutic approaches , 2013, Neurobiology of Disease.

[38]  S. Fatemi,et al.  The involvement of Reelin in neurodevelopmental disorders , 2013, Neuropharmacology.

[39]  Ben A. Barres,et al.  Emerging roles of astrocytes in neural circuit development , 2013, Nature Reviews Neuroscience.

[40]  M. Schwarz,et al.  Anti-inflammatory treatment in schizophrenia , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[41]  B. Yee,et al.  Deletion of striatal adenosine A2A receptor spares latent inhibition and prepulse inhibition but impairs active avoidance learning , 2013, Behavioural Brain Research.

[42]  R. Hen,et al.  BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities , 2013, Translational Psychiatry.

[43]  M. Nardini,et al.  Characterization of human DAAO variants potentially related to an increased risk of schizophrenia. , 2013, Biochimica et biophysica acta.

[44]  V. Haroutunian,et al.  Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia , 2013, Schizophrenia Research.

[45]  B. Yee,et al.  Dysregulation of brain adenosine is detrimental to the expression of conditioned freezing but not general Pavlovian learning , 2013, Pharmacology Biochemistry and Behavior.

[46]  A. Pillai,et al.  BDNF-TrkB signaling and neuroprotection in schizophrenia. , 2013, Asian journal of psychiatry.

[47]  P. Haydon,et al.  The Importance of astrocyte‐derived purines in the modulation of sleep , 2013, Glia.

[48]  L. Siever,et al.  Convergent Findings for Abnormalities of the NF-κB Signaling Pathway in Schizophrenia , 2013, Neuropsychopharmacology.

[49]  A. Quintana,et al.  Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior , 2013, Brain, Behavior, and Immunity.

[50]  L. Bianchi,et al.  Two Novel DEG/ENaC Channel Subunits Expressed in Glia Are Needed for Nose-Touch Sensitivity in Caenorhabditis elegans , 2013, The Journal of Neuroscience.

[51]  D. Hines,et al.  Antidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling , 2013, Translational Psychiatry.

[52]  Kenji F. Tanaka,et al.  Application of an optogenetic byway for perturbing neuronal activity via glial photostimulation , 2012, Proceedings of the National Academy of Sciences.

[53]  M. Pletnikov,et al.  Toxoplasma gondii and cognitive deficits in schizophrenia: an animal model perspective. , 2012, Schizophrenia bulletin.

[54]  B. Bogerts,et al.  Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood–brain barrier integrity , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[55]  X. Tong,et al.  Schizophrenia-Like Features in Transgenic Mice Overexpressing Human HO-1 in the Astrocytic Compartment , 2012, The Journal of Neuroscience.

[56]  E. Smeraldi,et al.  Cognitive dysfunction and glutamate reuptake: Effect of EAAT2 polymorphism in schizophrenia , 2012, Neuroscience Letters.

[57]  B. Yee,et al.  Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia. , 2012, The Journal of clinical investigation.

[58]  Jason H. Moore,et al.  Pathway analysis of genomic data: concepts, methods, and prospects for future development. , 2012, Trends in genetics : TIG.

[59]  G. Martinotti,et al.  Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review. , 2012, Journal of biological regulators and homeostatic agents.

[60]  S. Snyder,et al.  Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion , 2012, Molecular Psychiatry.

[61]  R. Schwarcz,et al.  Kynurenines in the mammalian brain: when physiology meets pathology , 2012, Nature Reviews Neuroscience.

[62]  F. Lung,et al.  Different Impacts of Aquaporin 4 and MAOA Allele Variation Among Olanzapine, Risperidone, and Paliperidone in Schizophrenia , 2012, Journal of clinical psychopharmacology.

[63]  D. Lewis,et al.  Cortical circuit dysfunction and cognitive deficits in schizophrenia – implications for preemptive interventions , 2012, The European journal of neuroscience.

[64]  M. Holtze,et al.  Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia. , 2012, Schizophrenia bulletin.

[65]  J. Waddington,et al.  Phenotypic effects of repeated psychosocial stress during adolescence in mice mutant for the schizophrenia risk gene neuregulin-1: A putative model of gene×environment interaction , 2012, Brain, Behavior, and Immunity.

[66]  R. Ransohoff,et al.  Innate immunity in the central nervous system. , 2012, The Journal of clinical investigation.

[67]  Randy F. Stout,et al.  Glial cells in (patho)physiology , 2012, Journal of neurochemistry.

[68]  L. Monteggia,et al.  Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders , 2012, Pharmacological Reviews.

[69]  Hai-Gwo Hwu,et al.  Genome-Wide Association Study of Treatment Refractory Schizophrenia in Han Chinese , 2012, PloS one.

[70]  Atsushi Kamiya,et al.  DISC1 Pathway in Brain Development: Exploring Therapeutic Targets for Major Psychiatric Disorders , 2012, Front. Psychiatry.

[71]  F. Georges,et al.  Acute Cannabinoids Impair Working Memory through Astroglial CB1 Receptor Modulation of Hippocampal LTD , 2012, Cell.

[72]  D. Weinberger,et al.  Mouse models of genetic effects on cognition: Relevance to schizophrenia , 2012, Neuropharmacology.

[73]  J. Feldon,et al.  Adenosine hypothesis of schizophrenia – Opportunities for pharmacotherapy , 2012, Neuropharmacology.

[74]  Jong Woo Kim,et al.  Association of thrombospondin 1 gene with schizophrenia in Korean population , 2012, Molecular Biology Reports.

[75]  Paul E. Gold,et al.  Lactate Produced by Glycogenolysis in Astrocytes Regulates Memory Processing , 2011, PloS one.

[76]  Herman Wolosker.  Serine racemase and the serine shuttle between neurons and astrocytes. , 2011, Biochimica et biophysica acta.

[77]  Urs Meyer,et al.  Anti-inflammatory signaling in schizophrenia , 2011, Brain, Behavior, and Immunity.

[78]  P. Magistretti,et al.  Altered Glycogen Metabolism in Cultured Astrocytes from Mice with Chronic Glutathione Deficit; Relevance for Neuroenergetics in Schizophrenia , 2011, PloS one.

[79]  R. Schwarcz,et al.  Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes. , 2011, Archives of general psychiatry.

[80]  R. Belmaker,et al.  The possible involvement of glycogen synthase kinase-3 (GSK-3) in diabetes, cancer and central nervous system diseases. , 2011, Current pharmaceutical design.

[81]  Urs Meyer,et al.  Schizophrenia and Autism: Both Shared and Disorder-Specific Pathogenesis Via Perinatal Inflammation? , 2011, Pediatric Research.

[82]  A. Arnsten.  Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia , 2011, International Journal of Developmental Neuroscience.

[83]  H. Scharfman,et al.  Impairment of Select Forms of Spatial Memory and Neurotrophin-Dependent Synaptic Plasticity by Deletion of Glial Aquaporin-4 , 2011, The Journal of Neuroscience.

[84]  A. Acker-Palmer,et al.  Ephrin Bs are essential components of the Reelin pathway to regulate neuronal migration , 2011, Nature.

[85]  Luísa V. Lopes,et al.  Adenosine and related drugs in brain diseases: present and future in clinical trials. , 2011, Current topics in medicinal chemistry.

[86]  Sarah A. Stern,et al.  Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory Formation , 2011, Cell.

[87]  J. Zhai,et al.  Risk variants in the S100B gene, associated with elevated S100B levels, are also associated with visuospatial disability of schizophrenia , 2011, Behavioural Brain Research.

[88]  Jens Boch,et al.  TALEs of genome targeting , 2011, Nature Biotechnology.

[89]  L. Siever,et al.  Astrocyte and Glutamate Markers in the Superficial, Deep, and White Matter Layers of the Anterior Cingulate Gyrus in Schizophrenia , 2011, Neuropsychopharmacology.

[90]  A. Dwork,et al.  Searching for Neuropathology: Gliosis in Schizophrenia , 2011, Biological Psychiatry.

[91]  P. Mcgeer,et al.  Astrocytes are GABAergic cells that modulate microglial activity , 2011, Glia.

[92]  Wei Wang,et al.  Is the EFNB2 locus associated with schizophrenia? Single nucleotide polymorphisms and haplotypes analysis , 2010, Psychiatry Research.

[93]  D. Javitt,et al.  N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia? , 2010, Brain Research Bulletin.

[94]  E. Jazin,et al.  QKI-7 Regulates Expression of Interferon-Related Genes in Human Astrocyte Glioma Cells , 2010, PloS one.

[95]  N. Stella.  Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomas , 2010, Glia.

[96]  B. Bogerts,et al.  Haloperidol and clozapine decrease S100B release from glial cells , 2010, Neuroscience.

[97]  E. Gundelfinger,et al.  Contributions of astrocytes to synapse formation and maturation — Potential functions of the perisynaptic extracellular matrix , 2010, Brain Research Reviews.

[98]  S. Cohen-Cory,et al.  Brain‐derived neurotrophic factor and the development of structural neuronal connectivity , 2010, Developmental neurobiology.

[99]  D. Attwell,et al.  Do astrocytes really exocytose neurotransmitters? , 2010, Nature Reviews Neuroscience.

[100]  D. Fuchs,et al.  Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction. , 2010, Journal of psychiatric research.

[101]  R. Schwarcz,et al.  Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia. , 2010, Schizophrenia bulletin.

[102]  T. Woo,et al.  Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia. , 2010, Archives of general psychiatry.

[103]  M. Sofroniew,et al.  Astrocytes: biology and pathology , 2009, Acta Neuropathologica.

[104]  F. Dickerson,et al.  Toxoplasma and schizophrenia , 2009, Parasite immunology.

[105]  Benjamin E. Deverman,et al.  Cytokines and CNS Development , 2009, Neuron.

[106]  L. Qi,et al.  Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics , 2009, Neuroscience Letters.

[107]  Akira Sawa,et al.  Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1–ErbB4 and DISC1 , 2009, Trends in Neurosciences.

[108]  Lei Wang,et al.  Glial ephrin-A3 regulates hippocampal dendritic spine morphology and glutamate transport , 2009, Proceedings of the National Academy of Sciences.

[109]  W. Byne,et al.  Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder , 2009, Schizophrenia Research.

[110]  B. Bogerts,et al.  Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy , 2009, Expert review of neurotherapeutics.

[111]  C. Brosnan,et al.  Deletion of Astrocyte Connexins 43 and 30 Leads to a Dysmyelinating Phenotype and Hippocampal CA1 Vacuolation , 2009, The Journal of Neuroscience.

[112]  M. Schroeter,et al.  Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia — Original research and meta-analysis , 2009, Psychiatry Research.

[113]  M. Bellesi,et al.  GLT‐1 upregulation impairs prepulse inhibition of the startle reflex in adult rats , 2009, Glia.

[114]  C. Freitag,et al.  Risk variants in the S100B gene predict elevated S100B serum concentrations in healthy individuals , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[115]  Jing-ping Zhao,et al.  The Interaction of Nuclear Factor-Kappa B and Cytokines Is Associated with Schizophrenia , 2009, Biological Psychiatry.

[116]  A. Guidotti,et al.  The Reelin and GAD67 Promoters Are Activated by Epigenetic Drugs That Facilitate the Disruption of Local Repressor Complexes , 2009, Molecular Pharmacology.

[117]  Michael M. Halassa,et al.  Astrocytic Modulation of Sleep Homeostasis and Cognitive Consequences of Sleep Loss , 2009, Neuron.

[118]  S. Oliet,et al.  Regulation of N-methyl-d-aspartate receptors by astrocytic d-serine , 2009, Neuroscience.

[119]  T. Suslow,et al.  Memory impairment correlates with increased S100B serum concentrations in patients with chronic schizophrenia , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[120]  M. Banasr,et al.  Glial Loss in the Prefrontal Cortex Is Sufficient to Induce Depressive-like Behaviors , 2008, Biological Psychiatry.

[121]  M. Pletnikov,et al.  Astrocytes play a key role in activation of microglia by persistent Borna disease virus infection , 2008, Journal of Neuroinflammation.

[122]  R. Murray,et al.  Gene-environment interactions in schizophrenia. Introduction. , 2008, Schizophrenia bulletin.

[123]  V. Haroutunian,et al.  Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia , 2008, Schizophrenia Research.

[124]  B. Bogerts,et al.  S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study. , 2008, Journal of psychiatric research.

[125]  R. Yolken,et al.  Are some cases of psychosis caused by microbial agents? A review of the evidence , 2008, Molecular Psychiatry.

[126]  Elena B Pasquale,et al.  Eph-Ephrin Bidirectional Signaling in Physiology and Disease , 2008, Cell.

[127]  A. Araque,et al.  Endocannabinoids Mediate Neuron-Astrocyte Communication , 2008, Neuron.

[128]  J. Feldon,et al.  Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs , 2007, The European journal of neuroscience.

[129]  K. Mirnics,et al.  Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6 , 2007, The Journal of Neuroscience.

[130]  E. J. Green,et al.  Astroglial nuclear factor‐κB regulates learning and memory and synaptic plasticity in female mice , 2007, Journal of neurochemistry.

[131]  A. Belli,et al.  S100B in neuropathologic states: The CRP of the brain? , 2007, Journal of neuroscience research.

[132]  M. Matsushita,et al.  A Genetic Variant of the Serine Racemase Gene Is Associated with Schizophrenia , 2007, Biological Psychiatry.

[133]  D. Bucci,et al.  Elevations of endogenous kynurenic acid produce spatial working memory deficits. , 2007, Schizophrenia bulletin.

[134]  R. Schwarcz,et al.  Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid? , 2007, Schizophrenia bulletin.

[135]  G. Burbaeva,et al.  Systemic Neurochemical Alterations in Schizophrenic Brain: Glutamate Metabolism in Focus , 2007, Neurochemical Research.

[136]  T. Suslow,et al.  Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[137]  S. Bauer,et al.  The neuropoietic cytokine family in development, plasticity, disease and injury , 2007, Nature Reviews Neuroscience.

[138]  M. Krebs.  Interactions gènes/environnement dans la schizophrénie , 2006 .

[139]  J. Deakin,et al.  Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder , 2006, Neuroscience Letters.

[140]  August G. Wang,et al.  Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. , 2006, American journal of human genetics.

[141]  V. Kapoor,et al.  Preliminary evidence for a link between schizophrenia and NMDA–glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1) , 2006, Brain Research.

[142]  V. Haroutunian,et al.  Serine racemase protein expression in cortex and hippocampus in schizophrenia , 2006, Neuroreport.

[143]  T. Suzuki,et al.  Association study between kynurenine 3‐monooxygenase gene and schizophrenia in the Japanese population , 2006, Genes, brain, and behavior.

[144]  J. Kleinman,et al.  Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia , 2005, Neuroscience.

[145]  Cathryn L. Kubera,et al.  Astrocytic Purinergic Signaling Coordinates Synaptic Networks , 2005, Science.

[146]  N. Fukui,et al.  Linkage disequilibrium in aquaporin 4 gene and association study with schizophrenia , 2005, Psychiatry and clinical neurosciences.

[147]  E. J. Green,et al.  Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury , 2005, The Journal of experimental medicine.

[148]  Emile G. Bruneau,et al.  Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia , 2005, Schizophrenia Research.

[149]  G. He,et al.  SNPs and haplotypes in the S100B gene reveal association with schizophrenia. , 2005, Biochemical and biophysical research communications.

[150]  C. Matute,et al.  Increased expression of the astrocytic glutamate transporter GLT‐1 in the prefrontal cortex of schizophrenics , 2005, Glia.

[151]  H. Schipper.  Heme oxygenase expression in human central nervous system disorders. , 2004, Free radical biology & medicine.

[152]  P. Falkai,et al.  Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF , 2004, Molecular Psychiatry.

[153]  R. Sidwell,et al.  Glial fibrillary acidic protein and glutamic acid decarboxylase 65 and 67 kDa proteins are increased in brains of neonatal BALB/c mice following viral infection in utero , 2004, Schizophrenia Research.

[154]  R. Yolken,et al.  Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress , 2004, Molecular Psychiatry.

[155]  V. Arolt,et al.  S100B Serum Levels and Long-Term Improvement of Negative Symptoms in Patients with Schizophrenia , 2004, Neuropsychopharmacology.

[156]  R. Murray,et al.  Causal association between cannabis and psychosis: examination of the evidence , 2004, British Journal of Psychiatry.

[157]  P. Heinrich,et al.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.

[158]  G. Burbaeva,et al.  Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[159]  G. Rajkowska,et al.  Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia , 2002, Schizophrenia Research.

[160]  Pierre J Magistretti,et al.  Aquaporins in Brain: Distribution, Physiology, and Pathophysiology , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[161]  S. Itohara,et al.  Glial protein S100B modulates long-term neuronal synaptic plasticity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[162]  R. Yolken,et al.  Immunohistochemical Localization of Phosphorylated Glial Fibrillary Acidic Protein in the Prefrontal Cortex and Hippocampus from Patients with Schizophrenia, Bipolar Disorder, and Depression , 2001, Brain, Behavior, and Immunity.

[163]  R. Schwarcz,et al.  Increased cortical kynurenate content in schizophrenia , 2001, Biological Psychiatry.

[164]  C. Pariante,et al.  Glial cell abnormalities in major psychiatric disorders: the evidence and implications , 2001, Brain Research Bulletin.

[165]  R. Saunders,et al.  A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis , 2001, Brain Research Bulletin.

[166]  R. Yolken,et al.  Serial analysis of gene expression in the frontal cortex of patients with bipolar disorder , 2001, British Journal of Psychiatry.

[167]  S. Paul,et al.  Neuronal injury-induced expression and release of apolipoprotein E in mixed neuron/glia co-cultures: nuclear factor κB inhibitors reduce basal and lesion-induced secretion of apolipoprotein E , 2001, Neuroscience.

[168]  Solomon H. Snyder,et al.  D-Amino Acids as Putative Neurotransmitters: Focus on D-Serine , 2000, Neurochemical Research.

[169]  D. Holtzman,et al.  Neuroinflammation and Alzheimer’s disease: critical roles for cytokine/Aβ-induced glial activation, NF-κB, and apolipoprotein E , 2000, Neurobiology of Aging.

[170]  W. Honer,et al.  No evidence for astrogliosis in brains of schizophrenic patients. A post‐mortem study , 1999, Neuropathology and applied neurobiology.

[171]  A. Hashimoto,et al.  Free d-aspartate and d-serine in the mammalian brain and periphery , 1997, Progress in Neurobiology.

[172]  M. Casanova,et al.  Ultrastructural alterations of synaptic contacts and astrocytes in postmortem caudate nucleus of schizophrenic patients , 1996, Schizophrenia Research.

[173]  J. Roder,et al.  Conspecific exploration in the T-maze: Abnormalities in S100β transgenic mice , 1996, Physiology & Behavior.

[174]  Richard F. Thompson,et al.  Deficient Cerebellar Long-Term Depression, Impaired Eyeblink Conditioning, and Normal Motor Coordination in GFAP Mutant Mice , 1996, Neuron.

[175]  J. Kleinman,et al.  Choline acetyltransferase in schizophrenia. , 1993, The American journal of psychiatry.

[176]  J. Kleinman,et al.  Astrocytosis in the molecular layer of the dentate gyrus: A study in Alzheimer's disease and schizophrenia , 1990, Psychiatry Research: Neuroimaging.

[177]  R. Drake,et al.  Depressive symptoms in schizophrenia: comprehensive differential diagnosis. , 1988, Comprehensive psychiatry.

[178]  M. Yasamy.  Schizoaffective disorder: A dimensional approach , 1987, Acta psychiatrica Scandinavica.

[179]  T. Hirano,et al.  Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[180]  Stone Mh.  Drug-related schizophrenic syndromes. , 1973 .

[181]  N. Sousa,et al.  Astrocyte pathology in the prefrontal cortex impairs the cognitive function of rats , 2014, Molecular Psychiatry.

[182]  Maiken Nedergaard,et al.  Heterogeneity of astrocytic form and function. , 2012, Methods in molecular biology.

[183]  O. Andreassen,et al.  Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls. , 2012, Journal of psychiatry & neuroscience : JPN.

[184]  M. Schwarz,et al.  Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects. , 2011, Current pharmaceutical design.

[185]  M. Bellesi,et al.  Synaptic localization of GLT‐1a in the rat somatic sensory cortex , 2009, Glia.

[186]  M. Pletnikov.  Inducible and conditional transgenic mouse models of schizophrenia. , 2009, Progress in brain research.

[187]  Rüdiger Klein,et al.  Bidirectional modulation of synaptic functions by Eph/ephrin signaling , 2009, Nature Neuroscience.

[188]  J. Trojanowski,et al.  Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia , 1996, Acta Neuropathologica.

[189]  M. Barbacid.  Neurotrophic Factors and Their Receptors , 1995, Bio/Technology.